Determinants of Adiponectin Levels in Patients With Chronic Systolic Heart Failure

American Journal of Cardiology

Volumn 105, Issue 8, 2010, Pages 1147-1152

  Biolo, Andreia ^a   Shibata, Rei ^b   Ouchi, Noriyuki ^b   Kihara, Shinji ^c   Sonoda, Mina ^c   Walsh, Kenneth ^b   Sam, Flora ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; SPIRONOLACTONE; UREA;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; COMORBIDITY; CYTOKINE RELEASE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; GOUT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PLASMA; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SYSTOLIC HEART FAILURE; UNIVARIATE ANALYSIS; UREA NITROGEN BLOOD LEVEL;

ADIPONECTIN; ADRENERGIC BETA-ANTAGONISTS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 77950368372     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.12.015     Document Type: Article

References (30)

1. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270 (1995) 26746-26749
2. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D.R., Kumada M., Sato K., Schiekofer S., Ohashi K., Funahashi T., Colucci W.S., and Walsh K. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10 (2004) 1384-1389
3. Iwashima Y., Katsuya T., Ishikawa K., Ouchi N., Ohishi M., Sugimoto K., Fu Y., Motone M., Yamamoto K., Matsuo A., Ohashi K., Kihara S., Funahashi T., Rakugi H., Matsuzawa Y., and Ogihara T. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43 (2004) 1318-1323
4. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., and Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
5. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., Arita Y., Okamoto Y., Shimomura I., Hiraoka H., Nakamura T., Funahashi T., and Matsuzawa Y. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
6. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., and Hildebrandt P. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112 (2005) 1756-1762
7. George J., Patal S., Wexler D., Sharabi Y., Peleg E., Kamari Y., Grossman E., Sheps D., Keren G., and Roth A. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 92 (2006) 1420-1424
8. Haugen E., Furukawa Y., Isic A., and Fu M. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: a hospital cohort study. Int J Cardiol 125 (2008) 216-219
9. Takano H.O.J., Kodama Y., Kitta Y., Nakamura T., Mende A.K.K., Saito Y., Fujioka D., Kobayashi T., Yano T., Sano K., and Kugiyama K. Adiponectin is released from the heart in patients with heart failure. Int J Cardiol 132 (2009) 221-226
10. Menon V., Li L., Wang X., Greene T., Balakrishnan V., Madero M., Pereira A.A., Beck G.J., Kusek J.W., Collins A.J., Levey A.S., and Sarnak M.J. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 17 (2006) 2599-2606
11. Biolo A., Ramamurthy S., Connors L.H., O'Hara C.J., Meier-Ewert H.K., Soo Hoo P.T., Sawyer D.B., Seldin D.S., and Sam F. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition. Circ Heart Fail 1 (2008) 249-257
12. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
13. Osei K., Gaillard T., and Schuster D. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes. Obes Rev 13 (2005) 179-185
14. Wolfe B.E., Jimerson D.C., Orlova C., and Mantzoros C.S. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol (Oxf) 61 (2004) 332-338
15. Yaturu S., Daberry R.P., Rains J., and Jain S. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes. Cytokines 34 (2006) 219-223
16. Nakamura T., Funayama H., Kubo N., Yasu T., Kawakami M., Saito M., Momomura S., and Ishikawa S.E. Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ J 70 (2006) 1557-1562
17. Delporte M.L., Brichard S.M., Hermans M.P., Beguin C., and Lambert M. Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) 58 (2003) 22-29
18. Chen M.B., McAinch A.J., Macaulay S.L., Castelli L.A., O'Brien P.E., Dixon J.B., Cameron-Smith D., Kemp B.E., and Steinberg G.R. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 90 (2005) 3665-3672
19. Kirpichnikov D., McFarlane S.I., and Sowers J.R. Heart failure in diabetic patients: utility of beta-blockade. J Card Fail 9 (2003) 333-344
20. Schnabel R., Messow C.M., Lubos E., Espinola-Klein C., Rupprecht H.J., Bickel C., Sinning C., Tzikas S., Keller T., Genth-Zotz S., Lackner K.J., Munzel T.F., and Blankenberg S. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J 29 (2008) 649-657
21. Yamaji M., Tsutamoto T., Tanaka T., Kawahara C., Nishiyama K., Yamamoto T., Fujii M., and Horie M. Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure. Circ J 73 (2009) 1067-1073
22. Tsutamoto T., Tanaka T., Sakai H., Ishikawa C., Fujii M., Yamamoto T., and Horie M. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J 28 (2007) 1723-1730
23. Flynn K.E., Pina I.L., Whellan D.J., Lin L., Blumenthal J.A., Ellis S.J., Fine L.J., Howlett J.G., Keteyian S.J., Kitzman D.W., Kraus W.E., Miller N.H., Schulman K.A., Spertus J.A., O'Connor C.M., and Weinfurt K.P. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301 (2009) 1451-1459
24. Van Berendoncks AM, Beckers P, Hoymans VY, Possemiers N, Wuyts FL, Vrints CJ, Conraads VM. Exercise training reduces circulating adiponectin levels in patients with chronic heart failure. Clin Sci (Lond) Epub 2009 Aug 6.
25. Tsukamoto O., Fujita M., Kato M., Yamazaki S., Asano Y., Ogai A., Okazaki H., Asai M., Nagamachi Y., Maeda N., Shintani Y., Minamino T., Asakura M., Kishimoto I., Funahashi T., Tomoike H., and Kitakaze M. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol 53 (2009) 2070-2077
26. Ouchi N., Kihara S., Funahashi T., Nakamura T., Nishida M., Kumada M., Okamoto Y., Ohashi K., Nagaretani H., Kishida K., Nishizawa H., Maeda N., Kobayashi H., Hiraoka H., and Matsuzawa Y. Reciprocal association of C-reactive protein with adiponectin in bloodstream and adipose tissue. Circulation 107 (2003) 671-674
27. Zoccali C., Mallamaci F., Panuccio V., Tripepi G., Cutrupi S., Parlongo S., Catalano F., Tanaka S., Ouchi N., Kihara S., Funahashi T., and Matsuzawa Y. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int Suppl 84 (2003) S98-S102
28. Skurk C., Wittchen F., Suckau L., Witt H., Noutsias M., Fechner H., Schultheiss H.P., and Poller W. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Eur Heart J 29 (2008) 1168-1180
29. Mullen K.L., Smith A.C., Junkin K.A., and Dyck D.J. Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats. Am J Physiol Endocrinol Metab 293 (2007) E83-E90
30. Wong G.W., Krawczyk S.A., Kitidis-Mitrokostas C., Revett T., Gimeno R., and Lodish H.F. Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J 416 (2008) 161-177